Stacie J Bell
Overview
Explore the profile of Stacie J Bell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
254
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gondo G, Noe M, Bell S, Ritchlin C
J Psoriasis Psoriatic Arthritis
. 2024 Sep;
7(1):17-23.
PMID: 39296733
Development and dissemination of novel COVID-19 vaccines represent an opportunity to end the COVID-19 pandemic by vaccinating an estimated 80% of the population. This study examines perceptions, and demographic and...
2.
Zundell M, Ogdie-Beatty A, Perez-Chada L, Hamade H, Gondo G, Khan A, et al.
JID Innov
. 2024 Aug;
4(5):100292.
PMID: 39149524
The National Psoriasis Foundation surveyed a random, stratified sample of individuals with psoriatic disease in the United States to determine the prevalence of an unacceptable psoriatic arthritis (PsA) symptom state...
3.
Gondo G, Mosca M, Hong J, Maverakis E, Merola J, Armstrong A, et al.
Dermatol Ther (Heidelb)
. 2022 Jul;
12(8):1885-1895.
PMID: 35864377
Introduction: Achievement of remission in psoriatic arthritis is a key goal for patients and clinicians, yet definitions of remission may vary. Previous efforts have utilized multidomain measures such as minimal...
4.
Gondo G, Hadeler E, Brownstone N, Maverakis E, Merola J, Armstrong A, et al.
Dermatol Ther (Heidelb)
. 2022 Mar;
12(3):753-760.
PMID: 35254634
Introduction: Achievement of remission in psoriasis is a key goal for patients and providers, yet definitions of remission may vary. Some treat-to-target initiatives in psoriasis have focused on degree of...
5.
Gondo G, Koons S, Metcalf C, Bell S, Mehta N
JID Innov
. 2021 Dec;
1(2):100007.
PMID: 34909711
No abstract available.
6.
Balak D, Perez-Chada L, Guo L, Mita C, Armstrong A, Bell S, et al.
J Invest Dermatol
. 2021 Nov;
142(7):2026-2029.e4.
PMID: 34838615
No abstract available.
7.
Armstrong A, Mehta M, Schupp C, Gondo G, Bell S, Griffiths C
JAMA Dermatol
. 2021 Jun;
157(8):940-946.
PMID: 34190957
Importance: Determining psoriasis prevalence is fundamental to understanding the burden of the disease, the populations most affected, and health policies to address the disease. Objective: (1) To determine the prevalence...
8.
Armstrong A, Archuleta L, Gutierrez Y, Liao W, Bell S, Gondo G
J Invest Dermatol
. 2021 Apr;
141(10):2539-2541.
PMID: 33862067
No abstract available.
9.
Lomeli B, Galbraith H, Schettler J, Saviolakis G, El-Amin W, Osborn B, et al.
Antimicrob Agents Chemother
. 2019 Nov;
64(1).
PMID: 31685472
CRS3123 is a novel small molecule that potently inhibits methionyl-tRNA synthetase of , inhibiting toxin production and spore formation. CRS3123 has been evaluated in a multiple-ascending-dose placebo-controlled phase 1 trial....
10.
Smith M, Ly K, Thibodeaux Q, Weerasinghe T, Beck K, Shankle L, et al.
Dermatol Ther (Heidelb)
. 2019 Jun;
9(3):511-523.
PMID: 31177381
Introduction: Sleep is essential for overall health and well-being, yet more than one-third of adults report inadequate sleep. The prevalence is higher among people with psoriasis, with up to 85.4%...